Wanjin Hong
Company: Biomedical Research Council (BMRC) at A*STAR
Job title: Chief Business Development Officer
Seminars:
Developing Effective Covalent Inhibitors Against TEAD as Candidates for Cancer Therapy 8:30 am
Download the Brochure to View the Session DetailsRead more
day: Day Two Morning
Panel Discussion: Advancing Hippo Pathway Combination Strategies: Exploring Current & Future Cross-Pathway Opportunities 9:00 am
Download the Brochure to View the Session DetailsRead more
day: Day One Morning